Arkolith/Insider Trading/GANX/Form 4

Richman Eric I

DirectorGain Therapeutics, Inc. (GANX) · full profile →Form 4 · filed Jul 1, 2024
Net Buying
Open-Market Buys
$21K
Open-Market Sells
$0
Net Open-Market Flow
$21K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 1, 2024Buy(P)5K$1.23$6K278K
Jul 1, 2024Buy(P)12K$1.21$15K290K

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001493152-24-025831) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML